Think of biotech and the bioeconomy as a broad methodology encompassing all those who use and borrow from biology to produce ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Prediction: This Biotech Stock Is Heading for a Once-in-a-Generation Opportunity was originally published by The Motley Fool ...

Ray Dalio’s firm cuts 20% of its Microsoft stock holding, signaling a shift in tech focus. Cathie Wood’s Ark Invest also ...

The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...

Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated ...

A resurfaced video of Vivek Ramaswamy at 18 delivering a graduation speech at St. Xavier High School has gained traction ...

Glassdoor, Payscale, or more specifically BioPharmGuy (to look through a large variety of job offers similar to yours) are ...

Trump said in a statement Tuesday night that Ramaswamy and Musk—the wealthiest person in the world, who oversees six ...

Wilmington Trust, the wealth management arm of M&T Bank, announced it has hired Karen… Shawmut Design and Construction, a $1.6 billion national construction management firm, celebrated the ...

So what does this mean for the future of biotech? Some investors and entrepreneurs are focused further downstream, finding very late-stage and even revenue-stage products. Some have shifted to ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an innovative biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, announces shareholder approval in connection with ...